Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical Trial
Varnaseri et al., Jundishapur Journal of Health Sciences, doi:10.5812/jjhs-146703
https://c19ivm.org/varnaseri.html